2 Sources
[1]
Firefly Neuroscience to Participate in Upcoming October Investor Conferences By Investing.com
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (Firefly, we, or the Company) (NASDAQ: AIFF), an Artificial Intelligence (AI) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that management will participate in the following October 2024 investor conferences: To schedule a one-on-one investor meeting with Mr. Olsen, please contact your representatives at Maxim, ThinkEquity or email KCSA Strategic Communications at [email protected]. About Firefly Firefly (NASDAQ: AIFF) is an Artificial Intelligence (AI) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly's FDA-510(k) cleared Brain Network (LON:NETW) Analytics (BNAâ„¢) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNAâ„¢ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use. Brain Network Analytics was developed using artificial intelligence and machine learning on Firefly's extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. BNAâ„¢, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function. These insights can enhance a clinician's ability to accurately diagnose mental and cognitive disorders and to evaluate what therapy and/or drug is best suited to optimize a patient's outcome. Please visit https://fireflyneuro.com/ for more information.
[2]
Firefly Neuroscience to Participate in Upcoming October Investor Conferences - Firefly Neuroscience (NASDAQ:AIFF)
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") AIFF, an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that management will participate in the following October 2024 investor conferences: Maxim Healthcare Virtual Summit Details: Date: October 15-17, 2024 Presentation Format: Fireside Chat with Maxim Analyst, Allen Klee Presentation Day and Time: Thursday, October 17th at 10:00 a.m. ET Webcast: https://investors.fireflyneuro.com/events-presentations ThinkEquity Conference Details: Date: October 30, 2024 Location: Mandarin Oriental Hotel, New York, NY Presentation Day and Time: Wednesday, October 30th at 11:00 a.m. ET Webcast: https://investors.fireflyneuro.com/events-presentations To schedule a one-on-one investor meeting with Mr. Olsen, please contact your representatives at Maxim, ThinkEquity or email KCSA Strategic Communications at [email protected]. About Firefly Firefly AIFF is an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly's FDA-510(k) cleared Brain Network Analytics (BNAâ„¢) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNAâ„¢ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use. Brain Network Analytics was developed using artificial intelligence and machine learning on Firefly's extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. BNAâ„¢, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function. These insights can enhance a clinician's ability to accurately diagnose mental and cognitive disorders and to evaluate what therapy and/or drug is best suited to optimize a patient's outcome. Please visit https://fireflyneuro.com/ for more information. Investor Contact KCSA Strategic Communications Valter Pinto or Jack Perkins (212) 896-1254 [email protected] Media Contact KCSA Strategic Communications Raquel Cona, Vice President (516) 779-2630 [email protected] Market News and Data brought to you by Benzinga APIs
Share
Copy Link
Firefly Neuroscience, an AI company specializing in brain health diagnostics, announces its participation in two major investor conferences in October 2024, highlighting its innovative Brain Network Analytics technology.
Firefly Neuroscience, Inc. (NASDAQ: AIFF), an innovative AI company focused on improving brain health outcomes, has announced its participation in two significant investor conferences this October. The company, which specializes in developing solutions for patients with neurological and mental disorders, aims to showcase its groundbreaking technology to potential investors and industry professionals 12.
The company will be participating in two distinct events:
Maxim Healthcare Virtual Summit (October 15-17, 2024):
ThinkEquity Conference (October 30, 2024):
Investors interested in one-on-one meetings with Firefly's management can arrange them through their Maxim or ThinkEquity representatives, or by contacting KCSA Strategic Communications 2.
At the heart of Firefly's offerings is its FDA-510(k) cleared Brain Network Analytics (BNAâ„¢) technology. This AI-driven solution is revolutionizing the diagnosis and treatment monitoring of various neurological and mental health conditions, including depression, dementia, anxiety disorders, concussions, and ADHD 1.
The BNAâ„¢ technology leverages artificial intelligence and machine learning, drawing insights from Firefly's extensive proprietary database. This database comprises standardized, high-definition longitudinal electroencephalograms (EEGs) from over 17,000 patients, representing twelve different disorders as well as clinically normal patients 2.
Firefly is currently in the process of launching BNAâ„¢ commercially. The company is targeting two primary markets:
When used in conjunction with an FDA-cleared EEG system, BNAâ„¢ provides clinicians with comprehensive insights into brain function. These insights can significantly enhance a clinician's ability to accurately diagnose mental and cognitive disorders and determine the most suitable therapy or drug to optimize patient outcomes 12.
As an AI company in the healthcare sector, Firefly Neuroscience is positioning itself at the intersection of technology and brain health. With its FDA clearance, patent protection, and a database built over 15 years, the company appears to be well-positioned to capitalize on the growing demand for innovative mental health solutions 1.
The upcoming investor conferences present a significant opportunity for Firefly to showcase its technology and business model to potential investors and partners. As the company moves forward with its commercial launch, these events could play a crucial role in securing additional funding and partnerships to fuel its growth and market expansion 2.
Google launches its new Pixel 10 series, featuring improved AI capabilities, enhanced camera systems, and the new Tensor G5 chip. The lineup includes the base Pixel 10, Pixel 10 Pro, Pixel 10 Pro XL, and Pixel 10 Pro Fold, all showcasing Google's commitment to AI-driven smartphone technology.
70 Sources
Technology
21 hrs ago
70 Sources
Technology
21 hrs ago
Google launches its new Pixel 10 smartphone series, featuring advanced AI capabilities powered by Gemini, aiming to challenge competitors in the premium handset market.
24 Sources
Technology
21 hrs ago
24 Sources
Technology
21 hrs ago
Google's latest Pixel Watch 4 introduces a curved display, AI-powered health coaching, and satellite communication, setting new standards in the smartwatch market.
19 Sources
Technology
21 hrs ago
19 Sources
Technology
21 hrs ago
FieldAI, an Irvine-based startup, has raised $405 million to develop "foundational embodied AI models" for various robots, aiming to create adaptable and safe AI systems for real-world applications.
8 Sources
Technology
21 hrs ago
8 Sources
Technology
21 hrs ago
Mustafa Suleyman, CEO of Microsoft AI, cautions about the risks of AI systems that appear conscious, urging the industry to avoid creating illusions of sentience in AI products.
5 Sources
Technology
21 hrs ago
5 Sources
Technology
21 hrs ago